Tatsuhiko Imaoka Selected Research

Angiotensin II

1/2016

A Rat Model to Study the Effects of Diet-Induced Obesity on Radiation-Induced Mammary Carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuhiko Imaoka Research Topics

Disease

25	Neoplasms (Cancer) 03/2022 - 10/2003
13	Carcinogenesis 01/2022 - 11/2004
13	Carcinoma (Carcinomatosis) 01/2021 - 09/2007
11	Breast Neoplasms (Breast Cancer) 03/2019 - 05/2006
3	Second Primary Neoplasms (Neoplasms, Second) 10/2019 - 04/2011
3	Lymphoma (Lymphomas) 01/2013 - 10/2003
1	Body Weight (Weight, Body) 03/2022
1	Iron Overload 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Obesity 01/2016
1	Radiation-Induced Neoplasms (Neoplasms, Radiation Induced) 02/2013
1	Colorectal Neoplasms (Colorectal Cancer) 04/2011
1	Neoplasm Metastasis (Metastasis) 09/2007
1	Colitis 01/2006
1	Colonic Neoplasms (Colon Cancer) 01/2006
1	Adenomyosis 11/2003
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2003

Drug/Important Bio-Agent (IBA)

9	CarcinogensIBA 01/2021 - 06/2005
7	Proteins (Proteins, Gene)FDA Link 03/2017 - 06/2005
6	CarbonIBA 10/2019 - 10/2003
5	IonsIBA 10/2019 - 10/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2010
4	Hormones (Hormone)IBA 01/2021 - 07/2011
3	Biological ProductsIBA 10/2017 - 01/2010
2	Insulin (Novolin)FDA Link 03/2022 - 01/2016
2	LeptinIBA 03/2022 - 01/2016
2	Phenobarbital (Luminal)FDA Link 01/2021 - 03/2019
2	Estrogen ReceptorsIBA 01/2018 - 07/2011
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 07/2011
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 04/2014 - 11/2011
2	beta CateninIBA 02/2006 - 01/2006
1	CholesterolIBA 03/2022
1	Triglycerides (Triacylglycerol)IBA 03/2022
1	ferric nitrilotriacetateIBA 01/2022
1	IronIBA 01/2022
1	Polycomb Repressive Complex 2IBA 01/2018
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Progesterone FDA LinkGeneric 01/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2016
1	Angiotensin Receptor AntagonistsIBA 01/2016
1	ReninIBA 01/2016
1	AngiotensinsIBA 01/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016
1	Angiotensin IIIBA 01/2016
1	candesartanIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 05/2014
1	RNA (Ribonucleic Acid)IBA 02/2013
1	MicroRNAs (MicroRNA)IBA 02/2013
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2013
1	A-Form DNA (A-DNA)IBA 01/2013
1	benzocycloheptapyridineIBA 11/2011
1	TOR Serine-Threonine KinasesIBA 11/2011
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2011
1	Protein Isoforms (Isoforms)IBA 11/2011
1	Therapeutic UsesIBA 11/2011
1	Sirolimus (Rapamycin)FDA Link 11/2011
1	ErbB Receptors (EGF Receptor)IBA 07/2011
1	LigandsIBA 07/2011
1	Estrogens (Estrogen)FDA Link 07/2011
1	Messenger RNA (mRNA)IBA 08/2010
1	Nonsense Codon (Nonsense Mutation)IBA 04/2010
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 04/2010
1	Untranslated RNA (Noncoding RNA)IBA 07/2008
1	Estrogen Receptor alphaIBA 09/2007
1	Dihydrotachysterol (AT 10)IBA 01/2006
1	Dextrans (Dextran)FDA Link 01/2006
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2006
1	Drinking WaterIBA 01/2006
1	Codon (Codons)IBA 06/2005
1	thymosin beta(4)IBA 11/2003
1	T-Lymphocyte Differentiation Antigens (Antigens, Differentiation, T Lymphocyte)IBA 10/2003

Therapy/Procedure

6	Radiotherapy 03/2022 - 04/2011
3	Therapeutics 01/2022 - 01/2010
2	Aftercare (After-Treatment) 01/2021 - 03/2013
1	Heavy Ion Radiotherapy 01/2010